Deubzer, Hedwig E.

HDAC family: What are the cancer relevant targets?

Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters

Histone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation

Cited by 1,069

Histone deacetylase 8 in neuroblastoma tumorigenesis

Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research

Neuroblastoma Research and TreatmentsHistone Deacetylase Inhibitors Research

Cited by 398

Histone deacetylase 10 promotes autophagy-mediated cell survival

Oehme, I., Linke, J.-P., Böck, B. C., Milde, T., Lodrini, M., Hartenstein, B., Wiegand, I., Eckert, C., Roth, W., Kool, M., et al. (2013) · Proceedings of the National Academy of Sciences

Autophagy in Disease and TherapyNeuroblastoma Research and Treatments

Cited by 221

HDAC11 is a novel drug target in carcinomas

Deubzer, H. E., Schier, M. C., Oehme, I., Lodrini, M., Haendler, B., Sommer, A., & Witt, O. (2013) · International Journal of Cancer

Histone Deacetylase Inhibitors ResearchEnzyme function and inhibition

Cited by 112

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma

Arnhold, V., Schmelz, K., Proba, J., Winkler, A., Wünschel, J., Toedling, J., Deubzer, H. E., Künkele, A., Eggert, A., Schulte, J. H., et al. (2018) · Oncotarget

Neuroblastoma Research and TreatmentsCancer-related Molecular Pathways

Cited by 85

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

Thole, T. M., Lodrini, M., Fabian, J., Wuenschel, J., Pfeil, S., Hielscher, T., Kopp-Schneider, A., Heinicke, U., Fulda, S., Witt, O., et al. (2017) · Cell Death & Disease

Neuroblastoma Research and TreatmentsHistone Deacetylase Inhibitors Research

Cited by 67